Ann: AusCann Investor Webinar, page-92

Agree.

This is clearly some kind of bias, but I found confidence in the way he very clearly confirmed that the capsules exist and are ready.

What made me like AC8 in the first place is their overall strategy and pharma approach, which still seems valid to me - despite the frustrating delays and seeming 12 months of doing nothing.

key times for stock price movement will be commencement of trial, completion of trial, phase 2 trials then of course phase 3.

not sure whetyer any partnerships or even minor sales via SAS would move the dial.